Daniel Watford, Md, Mph - Apol1 Kidney Risk Variants And The Apollo Study

Daniel Watford, MD, MPH - APOL1 Kidney Risk Variants and the APOLLO Study

University of Washington Division of Nephrology

Daniel Watford, MD, MPH - Frailty and Physical Function Evaluation in Kidney Transplantation

University of Washington Division of Nephrology

Role of the APOL1 Gene in Kidney Disease | Barry Freedman, MD

The Apollo Network-13

National Kidney Foundation | APOLLO Consortium Facebook Live

The Apollo Network-13

APOL1-mediated kidney disease | Rare Kidney Disease | AKF

Adriana Hung, MD, MPH - APOL1 Mediated Kidney Disease: Toward Precision Medicine Approaches

University of Washington Division of Nephrology

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry Freedman

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex Pharmaceuticals

Vertex Pharmaceuticals

NMQF Webinar: Understanding Genetic Kidney Diseases: Insights into APOL1

National Minority Quality Forum

APOL1 & Kidney Disease: Progress Toward Precision Medicine | DoM Grand Rounds | 30 March 2022

Stanford Department of Medicine

Emerging Research with Global Implications: Identification & Diagnosis of Kidney Diseases - APOL1

American Association of Kidney Patients

Health Inequities, APOL1, and Chronic Kidney Disease in African Americans and Blacks

Recent Breakthroughs with the APOL1 Nephropathy Gene Risk Variant

Atrium Health Wake Forest Baptist

APOL1-Associated Kidney Diseases - Joshua Waitzman, MD, PhD

Increasing Awareness and Education of APOL1 Kidney Disease

American Society of Nephrology

Advances in APOL1 Therapeutics

GlomCon Foundation

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKF

6/21/17 - Session III: Daniel

NASEM Health and Medicine Division

APOL1 variant and renal disease. Half of Black Americans are affected.

APOL1 Gene and African-American Susceptibility to Chronic Kidney Disease by John Sedor, MD